首页 › 超重 › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 超重临床试验
14项针对 超重的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Clinical Renal Associates Ltd., Media · 距离 12 英里
- Suburban Research Associates, West Chester · 距离 24 英里
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Abington Medical Specialists, Horsham · 距离 16 英里
- Family Practice Associates, Wilmington · 距离 25 英里
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Keystone Clinical Studies, Plymouth Meeting · 距离 12 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Philadelphia
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Suburban Research Associates - West Chester Office, West Chester · 距离 24 英里
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Philadelphia
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
招募中3 期
- UPA Ctr Weight and Eating Dis, Philadelphia
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 距离 12 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Philadelphia
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Philadelphia
An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
招募中欢迎健康志愿者
- Drexel University, Philadelphia
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL28 项研究
- Orlando, FL27 项研究
- Las Vegas, NV23 项研究
- Miami, FL23 项研究
- Atlanta, GA20 项研究
- Dallas, TX20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Philadelphia的其他研究
- 癌症（所有类型）59 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 前列腺癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌28 项研究
- 抑郁症26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。